Hikma Pharmaceuticals PLC (HIK) — Capital Reinvestment Ratio
Latest as of June 2025:
0.42x
Hikma Pharmaceuticals PLC (HIK) has a Capital Reinvestment Ratio of 0.42x as of June 2025, meaning it reinvests 0% of its operating cash flow (GBX161.00 Million) in capital expenditures (GBX68.00 Million). See HIK FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.42x
Capex / Operating Cash Flow
Operating Cash Flow
GBX161.00 Million
GBX
Capital Expenditures
GBX68.00 Million
GBX
Data as of
Jun 2025
Most recent filing
Hikma Pharmaceuticals PLC Capital Reinvestment Ratio (2004–2024)
This chart tracks Hikma Pharmaceuticals PLC's Capital Reinvestment Ratio across 21 annual periods.
Annual Capital Reinvestment Ratio for Hikma Pharmaceuticals PLC (2004–2024)
Year-by-year Capital Reinvestment Ratio for Hikma Pharmaceuticals PLC from 2004 to 2024. For live market cap and broader valuation context, see Hikma Pharmaceuticals PLC market capitalisation.
| Year | Reinvestment Ratio | Operating CF (GBX) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.29x | GBX564.00 Million | GBX165.00 Million | ▲ +5.2% |
| 2023 | 0.28x | GBX608.00 Million | GBX169.00 Million | ▼ -34.5% |
| 2022 | 0.42x | GBX530.00 Million | GBX225.00 Million | ▲ +18.3% |
| 2021 | 0.36x | GBX638.00 Million | GBX229.00 Million | ▼ -25.6% |
| 2020 | 0.48x | GBX464.00 Million | GBX224.00 Million | ▲ +22.5% |
| 2019 | 0.39x | GBX472.00 Million | GBX186.00 Million | ▲ +58.4% |
| 2018 | 0.25x | GBX430.00 Million | GBX107.00 Million | ▲ +3.0% |
| 2017 | 0.24x | GBX443.00 Million | GBX107.00 Million | ▼ -42.0% |
| 2016 | 0.42x | GBX293.00 Million | GBX122.00 Million | ▲ +85.8% |
| 2015 | 0.22x | GBX366.00 Million | GBX82.00 Million | ▲ +4.6% |
| 2014 | 0.21x | GBX425.00 Million | GBX91.00 Million | ▲ +22.3% |
| 2013 | 0.18x | GBX337.00 Million | GBX59.00 Million | ▼ -64.6% |
| 2012 | 0.50x | GBX182.16 Million | GBX90.19 Million | ▼ -34.8% |
| 2011 | 0.76x | GBX102.64 Million | GBX78.00 Million | ▲ +98.3% |
| 2010 | 0.38x | GBX138.79 Million | GBX53.20 Million | ▲ +0.2% |
| 2009 | 0.38x | GBX105.52 Million | GBX40.38 Million | ▼ -66.2% |
| 2008 | 1.13x | GBX57.87 Million | GBX65.52 Million | ▼ -11.2% |
| 2007 | 1.28x | GBX43.12 Million | GBX54.99 Million | ▼ -27.1% |
| 2006 | 1.75x | GBX29.99 Million | GBX52.44 Million | ▲ +138.5% |
| 2005 | 0.73x | GBX32.71 Million | GBX23.98 Million | ▲ +12.9% |
| 2004 | 0.65x | GBX32.84 Million | GBX21.33 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow